American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,132 | -33,956 | -21,115 | -59,725 | -23,822 |
| Depreciation Amortization | 9,299 | 6,318 | 3,133 | 12,721 | 9,547 |
| Income taxes - deferred | 617 | 610 | 92 | 754 | 64 |
| Accounts receivable | 17,820 | 16,839 | 11,690 | -6,823 | 9,251 |
| Accounts payable and accrued liabilities | -3,657 | -3,153 | -1,424 | -6,368 | 1,979 |
| Other Working Capital | 17,124 | 19,544 | 12,744 | -7,168 | 10,066 |
| Other Operating Activity | -7,996 | -11,076 | -6,973 | 20,157 | -44,225 |
| Operating Cash Flow | $-21,927 | $-4,874 | $-1,853 | $-46,453 | $-37,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,120 | -1,376 | -358 | -18,663 | -9,349 |
| Purchase Of Investment | -214 | -597 | 21 | 18,329 | 14,380 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -3,970 | N/A |
| Other Investing Activity | 4,658 | 4,567 | 4,208 | 15,516 | 20,776 |
| Investing Cash Flow | $-10,676 | $2,595 | $3,871 | $15,182 | $25,807 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -14,898 | N/A | N/A | 18,914 | -3,827 |
| Debt Issued | 39,576 | 9,743 | N/A | N/A | 13,914 |
| Debt Repayment | N/A | -12,995 | N/A | -18,479 | -18,479 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,271 | -1,271 |
| Other Financing Activity | 2,390 | 4,459 | -1,697 | -14,650 | -6,781 |
| Financing Cash Flow | $27,069 | $1,207 | $-1,697 | $-15,486 | $-16,443 |
| Exchange Rate Effect | 1,668 | 980 | -1,002 | 1,227 | 1,580 |
| Beginning Cash Position | 7,097 | 7,097 | 7,097 | 52,628 | 52,628 |
| End Cash Position | 3,231 | 7,005 | 6,416 | 7,097 | 26,432 |
| Net Cash Flow | $-3,866 | $-92 | $-682 | $-45,531 | $-26,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,927 | -4,874 | -1,853 | -46,453 | -37,140 |
| Capital Expenditure | -15,120 | -1,376 | -358 | -18,663 | -9,348 |
| Free Cash Flow | -37,047 | -6,250 | -2,211 | -65,117 | -46,488 |